Induced Pluripotent Stem Cell (iPSC) Global Industry Report 2024 - Revolutionizing Medicine: The Transformative Power and Commercial Potential of Induced Pluripotent Stem Cells (iPSCs)
August 16, 2024 10:44 ET
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2024" report has been added to ResearchAndMarkets.com's...
Stromal Vascular Fraction Global Strategic Research Report 2024-2030: Extensive Therapeutic Scope Set to Stimulate Growth, Soft Tissue Segment Leads the Market
May 30, 2024 05:21 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Stromal Vascular Fraction - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Stromal Vascular...
Global Induced Pluripotent Stem Cell (iPSC) Industry Report, with Profiles Leading Market Competitors, Including FUJIFILM CDI, ReproCELL, Evotec, Ncardia and Axol Bioscience
April 29, 2024 06:49 ET
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's...
Induced Pluripotent Stem Cells (iPSCs) Production Market Worth $4.17 Billion by 2034: An Extensive Analysis of Instruments/Devices, Consumables, Kits, Services, Processes, Workflow Components, and Major Players
January 24, 2024 14:15 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Induced Pluripotent Stem Cells Production Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's...
Clinical Trials Using iPSCs for Heart Diseases, Stroke, and Cancer Treatment Propel Induced Pluripotent Stem Cell Market Growth
November 08, 2023 07:53 ET
|
Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Stromal Vascular Fraction Global Market to Reach $116.9 Million by 2030: Increased Prevalence of Musculoskeletal Disorders & Knee Osteoarthritis Steers Expansion
July 11, 2023 05:18 ET
|
Research and Markets
Dublin, July 11, 2023 (GLOBE NEWSWIRE) -- The "Stromal Vascular Fraction: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Stromal...
Stem Cell Cartilage Regeneration Global Market Report 2023: Increasing Research and Development Activities Boost Sector
May 19, 2023 04:33 ET
|
Research and Markets
Dublin, May 19, 2023 (GLOBE NEWSWIRE) -- The "Stem Cell Cartilage Regeneration Market, by Stem Cell Type, by Treatment, By End User and by Region, and By Geography - Size, Share, Outlook, and...
Global Induced Pluripotent Stem Cell Market Report 2023: Cost-effective Benefits of iPSC for Drug Discovery Drive Growth
May 05, 2023 06:53 ET
|
Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering. ...
Global Induced Pluripotent Stem Cell (iPSC) Industry Report 2023: Significant Advancements in Stem Cell Biology and Regenerative Medicine Bolster Growth
February 13, 2023 05:53 ET
|
Research and Markets
Dublin, Feb. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2023" report has been added to ...
GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022
December 12, 2022 07:30 ET
|
GT Biopharma, Inc.
Presentation shows the therapeutic potential of combining iPSC-derived CAR NK cells and NK cell engagers to overcome the clinical heterogeneity of AML BRISBANE, CALIFORNIA, Dec. 12, 2022 (GLOBE...